Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Shared Hospital Services (AMS) Gains from Sales and Divestitures: 2020-2024

Historic Gains from Sales and Divestitures for American Shared Hospital Services (AMS) over the last 5 years, with FY2024 value amounting to $120000.0.

  • American Shared Hospital Services' Gains from Sales and Divestitures rose 344.83% to $120000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $120000.0, marking a year-over-year increase of 344.83%. This contributed to the annual value of $120000.0 for FY2024, which is 344.83% up from last year.
  • Per American Shared Hospital Services' latest filing, its Gains from Sales and Divestitures stood at $120000.0 for FY2024, which was up 344.83% from $116000.0 recorded in FY2023.
  • Over the past 5 years, American Shared Hospital Services' Gains from Sales and Divestitures peaked at $168000.0 during FY2021, and registered a low of $116000.0 during FY2023.
  • For the 5-year period, American Shared Hospital Services' Gains from Sales and Divestitures averaged around $134000.0, with its median value being $132000.0 (2022).
  • As far as peak fluctuations go, American Shared Hospital Services' Gains from Sales and Divestitures surged by 2537.31% in 2021, and later tumbled by 2142.86% in 2022.
  • American Shared Hospital Services' Gains from Sales and Divestitures (Annual) stood at $134000.0 in 2020, then grew by 25.37% to $168000.0 in 2021, then dropped by 21.43% to $132000.0 in 2022, then fell by 12.12% to $116000.0 in 2023, then rose by 3.45% to $120000.0 in 2024.
  • Its Gains from Sales and Divestitures was $120000.0 in FY2024, compared to $116000.0 in FY2023 and $132000.0 in FY2022.